Michael Okunewitch
Stock Analyst at Maxim Group
(0.37)
# 3,055
Out of 4,479 analysts
15
Total ratings
14.29%
Success rate
-20.48%
Average return
Main Sectors:
Top Industries:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics | Initiates: Buy | $4 | $0.97 | +314.08% | 1 | May 13, 2024 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $3 → $12 | $2.76 | +334.78% | 2 | Mar 5, 2024 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $24 | $5.86 | +309.56% | 1 | Oct 5, 2023 | |
| ANEB Anebulo Pharmaceuticals | Initiates: Buy | $6 | $2.68 | +123.88% | 1 | Sep 21, 2023 | |
| KPRX Kiora Pharmaceuticals | Maintains: Buy | $108 → $18 | $4.35 | +313.79% | 3 | Aug 9, 2023 | |
| ALZN Alzamend Neuro | Initiates: Buy | $23 | $0.41 | +5,405.26% | 1 | Apr 12, 2023 | |
| MDWD MediWound | Initiates: Buy | $25 | $15.39 | +62.44% | 1 | Dec 22, 2022 | |
| BRTX BioRestorative Therapies | Initiates: Buy | $6 | $1.98 | +203.03% | 1 | Sep 28, 2022 | |
| HCWB HCW Biologics | Initiates: Buy | $4 | $0.65 | +515.38% | 1 | Mar 24, 2022 | |
| LGVN Longeveron | Initiates: Buy | $140 | $1.57 | +8,817.20% | 1 | Mar 24, 2022 | |
| ATAI Atai Life Sciences | Initiates: Buy | n/a | $1.35 | - | 1 | Nov 30, 2021 | |
| CTXR Citius Pharmaceuticals | Initiates: Buy | n/a | $0.54 | - | 1 | Nov 30, 2021 |
Chemomab Therapeutics
May 13, 2024
Initiates: Buy
Price Target: $4
Current: $0.97
Upside: +314.08%
Lexaria Bioscience
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $12
Current: $2.76
Upside: +334.78%
Acrivon Therapeutics
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $5.86
Upside: +309.56%
Anebulo Pharmaceuticals
Sep 21, 2023
Initiates: Buy
Price Target: $6
Current: $2.68
Upside: +123.88%
Kiora Pharmaceuticals
Aug 9, 2023
Maintains: Buy
Price Target: $108 → $18
Current: $4.35
Upside: +313.79%
Alzamend Neuro
Apr 12, 2023
Initiates: Buy
Price Target: $23
Current: $0.41
Upside: +5,405.26%
MediWound
Dec 22, 2022
Initiates: Buy
Price Target: $25
Current: $15.39
Upside: +62.44%
BioRestorative Therapies
Sep 28, 2022
Initiates: Buy
Price Target: $6
Current: $1.98
Upside: +203.03%
HCW Biologics
Mar 24, 2022
Initiates: Buy
Price Target: $4
Current: $0.65
Upside: +515.38%
Longeveron
Mar 24, 2022
Initiates: Buy
Price Target: $140
Current: $1.57
Upside: +8,817.20%
Atai Life Sciences
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.35
Upside: -
Citius Pharmaceuticals
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $0.54
Upside: -